Search results
Author(s):
Marianna Fontana
Added:
2 years ago
Prof Marianna Fontana (University College London, UK) joined us to discuss the discovery and impact of antibody-associated reversal of ATTR amyloidosis–related cardiomyopathy in three patients.
Prof Fontana and her team, in a correspondence published in The New England Journal of Medicine, revealed the identification of an antibody linked to the spontaneous reversal of cardiac transthyretin…
View more
Author(s):
Eirik Ikdahl
,
Anne Kerola
,
Eli Sollerud
,
et al
Added:
1 year ago
Claire Lew
Research Area(s) / Expertise:
Job title: ISCP Governor for Singapore & Senior Pharmacist
Author
Factor XI Inhibition and AF
Author(s):
Bianca Rocca
,
Hugo ten Cate
Added:
11 months ago
Expert Opinion
Systematic Scoping on DOACS in NVAF Patients
Author(s):
Shirley Siang Ning Tan
,
Wei Hong Lai
,
Lee Len Tiong
,
et al
Added:
6 months ago
Review Article
Factor XIa Inhibitors’ Future Position in AF
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
1 year ago
Expert Opinion
Federico Pappalardo
Author
Jeffrey Weitz
Research Area(s) / Expertise:
Job title: Professor of Medicine and Biochemistry and Biomedical Sciences & Executive Director
Author
Author(s):
Rasha Al-Lamee
,
Christopher Rajkumar
,
Nazli Okumus
Added:
2 years ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA…
View more